PainReform Ltd. Files 6-K, Incorporates Press Release
Ticker: PRFX · Form: 6-K · Filed: Nov 20, 2024 · CIK: 1801834
| Field | Detail |
|---|---|
| Company | Painreform Ltd. (PRFX) |
| Form Type | 6-K |
| Filed Date | Nov 20, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, registration-statement, sec
Related Tickers: PAIN
TL;DR
PainReform (PAIN) filed a 6-K, incorporating a press release into its S-8 and F-3 filings.
AI Summary
PainReform Ltd. filed a Form 6-K on November 20, 2024, to report information for the month of November 2024. This filing incorporates by reference a press release into its existing Registration Statements on Form S-8 and Form F-3, which are used for the offering of securities.
Why It Matters
This filing indicates that PainReform Ltd. is making new information available to the public, which could affect investor decisions regarding its securities.
Risk Assessment
Risk Level: low — This is a routine filing that incorporates previously issued information into existing registration statements, with no new material financial or operational developments disclosed.
Key Players & Entities
- PainReform Ltd. (company) — Filer of the 6-K report
- November 20, 2024 (date) — Filing date of the 6-K
- Form S-8 (document) — Registration statement referenced in the filing
- Form F-3 (document) — Registration statement referenced in the filing
FAQ
What is the purpose of this Form 6-K filing by PainReform Ltd.?
The purpose of this Form 6-K is to report information for the month of November 2024 and to incorporate by reference a press release into the Company's Registration Statements on Form S-8 and Form F-3.
When was this Form 6-K filed with the SEC?
This Form 6-K was filed on November 20, 2024.
Which registration statements are being updated by this filing?
This filing updates Registration Statements on Form S-8 (Registration No. 333-257968 and 333-265902) and Registration Statements on Form F-3 (Registration No. 333-282264, 333-254982, 333-276485 and 333-277594).
What is PainReform Ltd.'s principal executive office address?
PainReform Ltd.'s principal executive offices are located at 65 Yigal Alon St., Tel Aviv 6744316, Israel.
Does PainReform Ltd. file annual reports under Form 20-F or Form 40-F?
PainReform Ltd. files annual reports under cover of Form 20-F.
Filing Stats: 259 words · 1 min read · ~1 pages · Grade level 9.3 · Accepted 2024-11-20 08:50:01
Filing Documents
- zk2432364.htm (6-K) — 11KB
- exhibit_99-1.htm (EX-99.1) — 12KB
- image00001.jpg (GRAPHIC) — 339KB
- 0001178913-24-003778.txt ( ) — 490KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Date: November 20, 2024 PAINREFORM LTD. By: /s/ Ehud Geller Ehud Geller Inteirm Chief Executive Officer